The impact of creativity on the development of bipolar disorders: results from a naturalistic, multi-centered cohort study
Year: 2023
Type: dissertation
Study design: Observational Study
Abstract: Background: Bipolar disorders belong to the most severe mental illnesses, characterized by recurrent depressive and (hypo-)manic episodes and an often chronic disease trajectory. Anecdotal data about famous creative individuals suggest a link between creativity and bipolar disorders (BD). To this day, only a few studies assessed persons at risk for BD and included creativity measures. Objective: This study aimed to further explore and understand the relationship between BD and creativity. For this purpose, we investigated the impact of creativity on a change in symptom severity in at-risk adolescents and young adults. This was defined as the transition to manifest BD and the initial prescription of a mood-stabilizing drug. Methods: The data were obtained from Early-BipoLife, a multicentered, prospective-longitudinal naturalistic cohort study conducted between 2015 and 2018. The participants aged between 15 and 35 were assessed five times over two years or longer. The adolescents and young adults were included in the study when they were screened positive for at least one of the potential risk factors for BD. After the exclusion of 150 participants due to incomplete early detection or creativity measures, the final sample included 1,105 at-risk individuals. The included participants were divided into four different groups, depending on their risk status according to the EPIbipolar and their scores in two creativity measures, the BWAS and the CAQ, respectively (G1: ↓ risk, ↓ creativity; G2: ↓ risk, ↑ creativity; G3: ↑ risk, ↓ creativity; G4: ↑ risk, ↑ creativity). Overall, 25 transitioned into manifest BD and 51 transitioned and/or received initial mood-stabilizing treatment. After the characterization of sociodemographic and clinical characteristics of the sample, the potential impact of creativity on the risk of transitioning to manifest BD and/or the initial prescription of a mood stabilizer was examined. For this, Odds Ratios (OR) and the corresponding 95% confidence intervals were calculated (G2, G3, G4 vs. G 1 as well as G4 vs. G3). This was done twice, one time using the BWAS and the other the CAQ as the creativity measure. Results: When comparing G2 vs. G1 using the EPIbipolar and the BWAS, no significant difference in the risk for transition to manifest BD and/or the initial prescription of a mood-stabilizing drug could be observed. The comparison of G3 vs. G1 revealed a significantly higher risk for transition to BD in G3 (OR = 4.56, 96% CI: 1.13 - 18.46, p = .029). In line with that are the results of the comparison of G4 vs. G1, revealing that the risk was even seven times higher for participants of G4 (OR = 7.05, 95% CI: 1.94 - 25.56, p = .001). Similar results could be observed when comparing G3 vs. G1 (OR = 2.31, CI: 1.02-5.26, p = .041) and G4 vs. G1 (OR = 2.92, CI: 1.38-6.19, p = .004) regarding the second outcome, transitions to manifest BD and/or the initial prescription of a mood stabilizer. The comparison of G4 vs. G3 revealed no significant differences in the risk of transition to BD and/or the initial prescription of a mood-stabilizing agent. The results were confirmed when repeating the analyses using the EPIbipolar and the CAQ, the second creativity measure. Conclusions: The longitudinal design enabled the present analysis to investigate the link between creativity and actual transitions into the manifest disease, making this the first study of this kind. The results suggest that creativity has a significant impact on the risk of developing BD in connection with other risk factors. Furthermore, it speaks in favor of the results, that there were no significant differences despite the very different ways the BWAS and the CAQ assess creativity. Therefore, creativity should be considered in risk evaluations of help-seeking young adults, as it usually presents itself much earlier than other clinical risk factors. Additionally, it is commonly experienced as a resource or positive sense of identity and might be reported more easily by affected individuals. Creativity should also be considered when it comes to the treatment of at-risk states or manifest BD. Knowledge about creative potential could be used in the diagnostic and therapeutic process and further improve compliance regarding psychological and pharmacological therapeutic interventions. For example, creative persons affected by BD might benefit from therapeutic options such as art or music therapy in addition to pharmaco- and psychotherapy. This is highly relevant because effective early interventions can possibly reduce negative consequences such as higher suicidality or psychosocial burden. Still, many aspects of the association between creativity, BD, and risk states remain unknown and need further research. Future studies should repeat the analysis, also implementing longitudinal designs, using different risk or creativity instruments as well as other statistical methods with the aim of investigating associations of creativity with other risk factors. The results showed that creativity cannot be used isolated to assess the risk status of help-seeking adolescents at this point. Therefore, it should not be pathologized but rather be viewed as a resource that can and should be integrated and considered when assessing and treating individuals at risk or with manifest BD.:List of Abbreviations List of Figures List of Tables Abstract German Abstract 1. Introduction 2. Theoretical Background 2.1 Early detection of bipolar disorders 2.1.1 Prodromal or risk state for bipolar disorders 2.1.2 Risk factors (according to EPIbipolar) and risk assessment tools 2.2 Creativity in association with bipolar disorders 2.2.1 Definitions of creativity 2.2.2 Measuring creativity 2.2.3 Investigation of the association between creativity and bipolar disorders 2.2.4 Creativity in persons at risk for bipolar disorders 2.3 Objectives and research questions 3. Methods 3.1 Sample 3.1.1 Overview of the sample 3.1.2 Comparison of excluded and included participants 3.2 Procedures 3.2.1 Quality assurance 3.2.2 Baseline assessment 3.2.3 Follow-up assessments 3.3 Measures 3.3.1 Structured Clinical Interview for DSM-IV Disorders (SCID) 3.3.2 Early Phase Inventory for Bipolar Disorders (EPIbipolar) 3.3.3 Barron-Welsh Art Scale (BWAS) 3.3.4 Creative Achievement Questionnaire (CAQ) 3.4 Group classification procedure and outcomes 3.4.1 Group classification procedure 3.4.2 Outcomes 3.5 Statistical analysis 4. Results 4.1 Descriptive Statistics 4.1.1 Comparison of sociodemographic characteristics between the study groups 4.2 Research Question 1: The impact of creativity on the transition to BD and/or the initial prescription of a mood stabilizer in study groups 1-4 4.2.1 Results for groups 2-4 versus 1 with the BWAS as a creativity measure 4.2.2 Results for groups 2-4 versus 1 with the CAQ as a creativity measure 4.3 Research Question 2: The impact of creativity on the transition to BD and/or the initial prescription of a mood stabilizer in study groups 3 and 4 4.3.1 Results for groups 4 versus 3 with the BWAS as a creativity measure 4.3.2 Results for groups 4 versus 3 with the CAQ as a creativity measure 5. Discussion 5.1 Summary and integration of findings 5.1.1 Comparison of sociodemographic characteristics between the study groups 5.1.2 Research Question 1: The impact of creativity on the transition to BD and/or the initial prescription of a mood stabilizer in two study groups 5.1.3 Research Question 2: The impact of creativity on the transition to BD and/or the initial prescription of a mood stabilizer in two study groups 5.2 Strengths and limitations 5.3 Implications for future research and practice 5.4 Conclusion 6. References Appendix
Author: Michaelis, Elisabeth Inka
Institution: Technische Universität Dresden
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7019762311
